Regeneron Pharmaceuticals
REGN
#307
Rank
A$114.07 B
Marketcap
A$1,108
Share price
-1.67%
Change (1 day)
25.46%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): A$7.73 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$14.91 Billion. In 2025 the company made an earning of A$7.29 Billion, an increase over its 2024 earnings that were of A$6.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$7.73 B6%
2025 A$7.29 B9.43%
2024 A$6.66 B13.83%
2023 A$5.85 B-13.57%
2022 A$6.77 B-47.9%
2021 A$13.01 B144.75%
2020 A$5.31 B56.86%
2019 A$3.38 B-4.87%
2018 A$3.56 B22.86%
2017 A$2.89 B56.3%
2016 A$1.85 B8.55%
2015 A$1.70 B54.53%
2014 A$1.10 B11.14%
2013 A$0.99 B72.13%
2012 A$0.57 B-285.93%
2011 -A$0.32 Billion121.73%
2010 -A$0.15 Billion37.18%
2009 -A$0.11 Billion-14.6%
2008 -A$0.12 Billion-25.02%
2007 -A$0.16 Billion6.32%
2006 -A$0.16 Billion-186.52%
2005 A$0.17 B2103.7%
2004 A$7.87 M-105.66%
2003 -A$0.14 Billion-18.18%
2002 -A$0.18 Billion42.33%
2001 -A$0.12 Billion129.35%
2000 -A$52.12 Million51.87%
1999 -A$34.32 Million92.19%
1998 -A$17.86 Million66.23%
1997 -A$10.75 Million-55.49%
1996 -A$24.14 Million103.53%
1995 -A$11.86 Million-70.89%
1994 -A$40.74 Million-26.08%
1993 -A$55.11 Million114.67%
1992 -A$25.67 Million196.77%
1991 -A$8.65 Million87.88%
1990 -A$4.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.24 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.02 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$12.67 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.68 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$2.26 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.21 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA